Larvol Delta - Agastiya-Biotech-receives-FDA-Orphan-Drug-Designation-for-AB001-for-Pancreatic-cancer-and-Acute-Myeloid-Leukemia-AML

AB001 - Agastiya Biotech

https://www.prnewswire.com/news-releases/agastiya-biotech-receives-fda-orphan-drug-designation-for-ab001-for-pancreatic-cancer-and-acute-myeloid-leukemia-aml-301538798.html

May 3, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev